✦ LIBER ✦

A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss

✍ Scribed by Jean Y. Reginster; Rita Deroisy; Marie P. Lecart; Nathalie Sarlet; Brigitte Zegels; Isabelle Jupsin; Marc de Longueville; Paul Franchimont

Book ID: 117017031
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 953 KB
Volume: 98
Category: Article
ISSN: 1555-7162
DOI: 10.1016/s0002-9343(99)80344-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Double Blind, Placebo-Controlled Trial

A Double Blind, Placebo-Controlled Trial of Ipriflavone for Prevention of Postmenopausal Spinal Bone Loss

✍ D. Agnusdei; G. Crepaldi; G. Isaia; G. Mazzuoli; S. Ortolani; M. Passeri; L. Buf 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 219 KB

Long-term (3 years) prevention of trabec

Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin

✍ J.Y. Reginster; D. Denis; R. Deroisy; M.P. Lecart; M. de Longueville; B. Zegels; 📂 Article 📅 2009 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 438 KB

Risedronate for prevention of bone miner

Risedronate for prevention of bone mineral density loss in patients receiving high-dose glucocorticoids: a randomized double-blind placebo-controlled trial

✍ C. C. Mok; K. H. Tong; C. H. To; Y. P. Siu; K. M. Ma 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 156 KB

The effect on bone mass and bone markers

The effect on bone mass and bone markers of different doses of ibandronate — A new bisphosphonate for prevention and treatment of postmenopausal osteoporosis. A 1-year, randomized, double-blind, placebo-controlled dose-finding study

✍ P. Ravn; B. Clemmesen; B. J. Riis; C. Christiansen 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 43 KB